Saenz, E. V. ., Golibkhon, A. ., & Ibragim, Y. . (2023). A comprehensive analysis of visfatin drug in type 2 diabetes, insulin resistance, and cardiovascular disease. Journal of Prevention, Diagnosis and Management of Human Diseases , 3(02), 1–8. https://doi.org/10.55529/jpdmhd.32.1.8